UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tofacitinib is an effective treatment for moderate to severe ulcerative colitis, and intestinal ultrasound can discriminate response from non-response: a pragmatic prospective real-world study

Annals of medicine (Helsinki), 2024-12, Vol.56 (1), p.2358183

2024

Volltextzugriff (PDF)

Risk of consecutive immunogenic failure in switchers of anti-tumor necrosis factor alpha among patients with inflammatory bowel diseases

Therapeutic advances in gastroenterology, 2022-01, Vol.15, p.17562848211068659-17562848211068659

2022

Volltextzugriff (PDF)

Editorial: risk of loss of response to anti‐TNFα agents in patients with inflammatory bowel disease—the longer the less?

Alimentary pharmacology & therapeutics, 2022-01, Vol.55 (2), p.244-245

2022

Volltextzugriff (PDF)

Clinical approach to skin eruptions induced by anti-TNF agents among patients with inflammatory bowel diseases: insights from a multidisciplinary IBD-DERMA clinic

Therapeutic advances in gastroenterology, 2021, Vol.14, p.17562848211053112-17562848211053112

2021

Volltextzugriff (PDF)

Extragastric Gastrointestinal Manifestations of Helicobacter Pylori: Friend or Foe?

EMJ. Gastroenterology, 2017-12, Vol.6 (1), p.61-68

2017

Volltextzugriff (PDF)

Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel Diseases

Vaccines (Basel), 2022-07, Vol.10 (8), p.1186

2022

Volltextzugriff (PDF)

Serologic Response and Safety after a Third Dose of the COVID-19 BNT162b2 Vaccine in Patients with Inflammatory Bowel Diseases

Vaccines (Basel), 2023-07, Vol.11 (7), p.1263

2023

Volltextzugriff (PDF)

Newly Diagnosed Crohn's Disease Patients in India and Israel Display Distinct Presentations and Serological Markers: Insights from Prospective Cohorts

Journal of clinical medicine, 2022-11, Vol.11 (23), p.6899

2022

Volltextzugriff (PDF)

Letter: 5‐aminosalicylate maintenance treatment in mild Crohn's disease—authors' reply

Alimentary pharmacology & therapeutics, 2023-05, Vol.57 (10), p.1184-1185

2023

Volltextzugriff (PDF)

Letter: the sphingosine 1 phosphate/sphingosine 1 phosphate receptor axis—a unique therapeutic target in inflammatory bowel disease. Authorsʼ reply

Alimentary pharmacology & therapeutics, 2022-05, Vol.55 (10), p.1360-1360

2022

Volltextzugriff (PDF)

NON-CASEATING GRANULOMAS ARE ASSOCIATED WITH STRICTURING CROHN’S DISEASE AND THEIR NUMBER AND SIZE ARE INCREASED IN THE MUSCULARIS PROPRIA OF STRICTURED COMPARED TO NON-STRICTURED INTESTINGAL SEGMENTS

Gastroenterology (New York, N.Y. 1943), 2024-02, Vol.166 (3), p.S83

2024

Volltextzugriff (PDF)

Reply

Clinical gastroenterology and hepatology, 2021-07, Vol.19 (7), p.1504-1505

2021

Volltextzugriff (PDF)

NON-CASEATING GRANULOMAS ARE ASSOCIATED WITH STRICTURING CROHN’S DISEASE AND THEIR NUMBER AND SIZE ARE INCREASED IN THE MUSCULARIS PROPRIA OF STRICTURED COMPARED TO NON-STRICTURED INTESTINGAL SEGMENTS

Inflammatory bowel diseases, 2024-01, Vol.30 (Supplement_1), p.S61-S61

2024

Volltextzugriff (PDF)

Endoscopic interventions for stricturing Crohn's disease

The lancet. Gastroenterology & hepatology, 2022-04, Vol.7 (4), p.279-280

2022

Volltextzugriff (PDF)

The Sphingosine 1 phosphate / Sphingosine 1 phosphate receptor axis: a unique therapeutic target in inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2022-02, Vol.55 (3), p.277-291

2022

Volltextzugriff (PDF)

Review article: the sphingosine 1 phosphate/sphingosine 1 phosphate receptor axis ‐ a unique therapeutic target in inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2022-02, Vol.55 (3), p.277-291

2022

Volltextzugriff (PDF)

Cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of patients with IBD

Gut, 2019-04, Vol.68 (4), p.604-614

2019

Volltextzugriff (PDF)

Muscular hyperplasia in Crohn's disease strictures: through thick and thin

American Journal of Physiology: Cell Physiology, 2024-09, Vol.327 (3), p.C671-C683

2024

Volltextzugriff (PDF)

Autoimmune/inflammatory syndrome induced by adjuvant (ASIA) evolution after silicone implants. Who is at risk?

Clinical rheumatology, 2015-10, Vol.34 (10), p.1661-1666

2015

Volltextzugriff (PDF)

The “Great Masquerader" Strikes Again: Secondary Syphilis Presentation with Erythema Multiforme (EM)-Like Lesions

European journal of case reports in internal medicine, 2014-12, Vol.1 (1)

2014

Volltextzugriff (PDF)

Novel Bioenhanced Curcumin With Mesalamine for Induction of Clinical and Endoscopic Remission in Mild-to-Moderate Ulcerative Colitis: A Randomized Double-Blind Placebo-controlled Pilot Study

Journal of clinical gastroenterology, 2021-09, Vol.55 (8), p.702-708

2021

Volltextzugriff (PDF)

Marked Improvement in Refractory TTP Directly after H. pylori Eradication Therapy

Case reports in hematology, 2016-01, Vol.2016 (2016), p.1-3

2016

Volltextzugriff (PDF)

Fecal Calprotectin Is Increased in Pouchitis and Progressively Increases With More Severe Endoscopic and Histologic Disease

Clinical gastroenterology and hepatology, 2022-08, Vol.20 (8), p.1839-1846.e2

2022

Volltextzugriff (PDF)

Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFα

Gastroenterology (New York, N.Y. 1943), 2022-02, Vol.162 (2), p.454-467

2022

Volltextzugriff (PDF)

TRIM7/RNF90 promotes autophagy via regulation of ATG7 ubiquitination during L. monocytogenes infection

Autophagy, 2023-06, Vol.19 (6), p.1844-1862

2023

Volltextzugriff (PDF)

1 – 25 von 98

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(89)

Publikationsform

Sprache

Englisch
(97)
Hebräisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Tofacitinib is an effective treatment for moderate to severe ulcerative colitis, and intestinal ultrasound can discriminate response from non-response: a pragmatic prospective real-world study

Risk of consecutive immunogenic failure in switchers of anti-tumor necrosis factor alpha among patients with inflammatory bowel diseases

Editorial: risk of loss of response to anti‐TNFα agents in patients with inflammatory bowel disease—the longer the less?

Clinical approach to skin eruptions induced by anti-TNF agents among patients with inflammatory bowel diseases: insights from a multidisciplinary IBD-DERMA clinic

Extragastric Gastrointestinal Manifestations of Helicobacter Pylori: Friend or Foe?

Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel Diseases

Serologic Response and Safety after a Third Dose of the COVID-19 BNT162b2 Vaccine in Patients with Inflammatory Bowel Diseases

Newly Diagnosed Crohn's Disease Patients in India and Israel Display Distinct Presentations and Serological Markers: Insights from Prospective Cohorts

Letter: 5‐aminosalicylate maintenance treatment in mild Crohn's disease—authors' reply

Letter: the sphingosine 1 phosphate/sphingosine 1 phosphate receptor axis—a unique therapeutic target in inflammatory bowel disease. Authorsʼ reply

NON-CASEATING GRANULOMAS ARE ASSOCIATED WITH STRICTURING CROHN’S DISEASE AND THEIR NUMBER AND SIZE ARE INCREASED IN THE MUSCULARIS PROPRIA OF STRICTURED COMPARED TO NON-STRICTURED INTESTINGAL SEGMENTS

Reply

NON-CASEATING GRANULOMAS ARE ASSOCIATED WITH STRICTURING CROHN’S DISEASE AND THEIR NUMBER AND SIZE ARE INCREASED IN THE MUSCULARIS PROPRIA OF STRICTURED COMPARED TO NON-STRICTURED INTESTINGAL SEGMENTS

Endoscopic interventions for stricturing Crohn's disease

The Sphingosine 1 phosphate / Sphingosine 1 phosphate receptor axis: a unique therapeutic target in inflammatory bowel disease

Review article: the sphingosine 1 phosphate/sphingosine 1 phosphate receptor axis ‐ a unique therapeutic target in inflammatory bowel disease

Cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of patients with IBD

Muscular hyperplasia in Crohn's disease strictures: through thick and thin

Autoimmune/inflammatory syndrome induced by adjuvant (ASIA) evolution after silicone implants. Who is at risk?

The “Great Masquerader" Strikes Again: Secondary Syphilis Presentation with Erythema Multiforme (EM)-Like Lesions

Novel Bioenhanced Curcumin With Mesalamine for Induction of Clinical and Endoscopic Remission in Mild-to-Moderate Ulcerative Colitis: A Randomized Double-Blind Placebo-controlled Pilot Study

Marked Improvement in Refractory TTP Directly after H. pylori Eradication Therapy

Fecal Calprotectin Is Increased in Pouchitis and Progressively Increases With More Severe Endoscopic and Histologic Disease

Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFα

TRIM7/RNF90 promotes autophagy via regulation of ATG7 ubiquitination during L. monocytogenes infection

Suchergebnisse filtern